Mayzent and Melatonin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mayzent (siponimod fumaric acid) and Melatonin (melatonin). Common drug interactions include dizziness among females and mood altered among males.

The phase IV clinical study analyzes what interactions people have when they take Mayzent and Melatonin. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 10,269 Mayzent users. Check the latest studies of Mayzent.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.



On Jul, 30, 2026

33 people who take Mayzent and Melatonin together, and have interactions are studied.

Mayzent and Melatonin drug interactions.

What are the common drug interactions of Mayzent and Melatonin, by gender? *:

female:

  1. Dizziness
  2. Headache (pain in head)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Nausea (feeling of having an urge to vomit)
  5. Fall
  6. Hallucination (an experience involving the perception of something not present)
  7. Abdominal pain upper
  8. Energy increased
  9. Pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

male:

  1. Mood altered (changes in mood)
  2. Apathy
  3. Total lung capacity decreased
  4. Adverse reaction
  5. Arthralgia (joint pain)
  6. Asthenia (weakness)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Liver disorder (liver diseases)

What are the common drug interactions of Mayzent and Melatonin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Headache (pain in head)

30-39:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Respiratory distress (difficulty in breathing)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

40-49:

  1. Agitation (state of anxiety or nervous excitement)
  2. Drug ineffective
  3. Hallucination (an experience involving the perception of something not present)
  4. Poor quality sleep
  5. Restlessness (not able to rest)

50-59:

  1. Dizziness
  2. Pain
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  5. Arrhythmia (irregular heartbeat)
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Ataxia (loss of full control of bodily movements)
  9. Back pain
  10. Balance disorder

60+:

  1. Dizziness
  2. Energy increased
  3. Fall
  4. Spinal fracture (fracture in one of vertebrae)
  5. Hallucination (an experience involving the perception of something not present)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Nausea (feeling of having an urge to vomit)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Vomiting

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 24 people, 72.73%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 15.15%
  3. Depression: 5 people, 15.15%
  4. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 3 people, 9.09%
  5. Rickets (softening of bones): 3 people, 9.09%
  6. Pain In Extremity: 3 people, 9.09%
  7. Nausea (feeling of having an urge to vomit): 3 people, 9.09%
  8. Muscle Spasms (muscle contraction): 3 people, 9.09%
  9. Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 3 people, 9.09%
  10. Weight Decreased: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and Melatonin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mayzent and Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mayzent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid and melatonin (the active ingredients of Mayzent and Melatonin, respectively), and Mayzent and Melatonin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: